Please login to the form below

Not currently logged in
Email:
Password:

Renewable energy

This page shows the latest Renewable energy news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk targets renewable energy switch by 2030

Novo Nordisk targets renewable energy switch by 2030

Huge solar panel array helps transition. Novo Nordisk wants to be the first pharma company to go fossil free and switch 100% to renewable energy sources by 2030. ... Meanwhile Johnson and Johnson, which is also a member of the RE100, has set a target to

Latest news

  • EC unveils €80bn R&D investment programme

    Finally, almost 32bn has been set aside to address "major concerns shared by all Europeans such as climate change, developing sustainable transport and mobility, making renewable energy more affordable, ensuring food

  • GSK plans to be carbon neutral by 2050

    This would mean the company would have no net carbon emissions along its production line, with GSK able to offset its emissions by investing in 'green' projects such as renewable energy, ... GSK would gain financially by saving £100m a year with reduced

  • Baxter UK launches carbon deliveries

    The pharmaceutical company says the project will offset its carbon footprint created by the total mileage between its distribution centre in Northampton and all Baxter customers by investing in renewable energy

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...